The favorable- and adverse-risk abnormal karyotypes were only aggregated in the NPM1mut/FLT3-ITD(−) group, implying possibly pathogenic independence between FLT3-ITD and those karyotypes in NPM1mut AML. The gene discussed is FLT3; the disease is acute myeloid leukemia.